The global polycystic ovary syndrome supplements market—valued at USD 1.17 billion in 2024 and growing at a CAGR of 14.13% through 2034—is rapidly segmenting along lines of ingredient composition, delivery format, and therapeutic intent, revealing distinct performance corridors driven by scientific backing and consumer behavior. Inositol-based supplements, particularly myo-inositol...
Bangla